EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 254 filers reported holding EXELIXIS INC in Q2 2017. The put-call ratio across all filers is 1.05 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $106,000 | +92.7% | 4,486 | +44.7% | 0.03% | +172.7% |
| Q4 2019 | $55,000 | -94.1% | 3,100 | -92.1% | 0.01% | -91.1% |
| Q1 2019 | $928,000 | +1074.7% | 39,252 | +772.3% | 0.12% | +726.7% |
| Q3 2018 | $79,000 | +29.5% | 4,500 | +55.2% | 0.02% | +7.1% |
| Q2 2018 | $61,000 | -84.9% | 2,900 | -83.9% | 0.01% | -85.9% |
| Q1 2018 | $403,000 | +560.7% | 18,030 | +792.6% | 0.10% | +607.1% |
| Q4 2017 | $61,000 | -97.1% | 2,020 | -97.9% | 0.01% | -94.3% |
| Q1 2017 | $2,117,000 | +210.0% | 97,700 | +113.3% | 0.24% | +183.7% |
| Q4 2016 | $683,000 | -35.9% | 45,800 | -45.1% | 0.09% | -37.2% |
| Q3 2016 | $1,066,000 | +162.6% | 83,363 | -17.8% | 0.14% | +191.5% |
| Q1 2016 | $406,000 | – | 101,400 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 17,416,738 | $422,007,000 | 64.06% |
| Matrix Capital Management Company, LP | 15,117,460 | $366,296,000 | 11.71% |
| Rhenman & Partners Asset Management AB | 1,050,000 | $25,442,000 | 3.25% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 254,334 | $6,163,000 | 2.40% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 790,148 | $19,145,000 | 1.30% |
| Jupiter Investment Management Ltd | 4,182,760 | $101,348,000 | 1.06% |
| INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 50,818 | $1,231,000 | 0.70% |
| C M BIDWELL & ASSOCIATES LTD | 17,475 | $423,000 | 0.65% |
| QCM Cayman, Ltd. | 9,562 | $232,000 | 0.60% |
| Handelsinvest Investeringsforvaltning | 98,500 | $2,387,000 | 0.56% |